KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Inventory: 2018-2025

Historic Inventory for Rigel Pharmaceuticals (RIGL) over the last 8 years, with Sep 2025 value amounting to $13.3 million.

  • Rigel Pharmaceuticals' Inventory rose 178.07% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 178.07%. This contributed to the annual value of $6.0 million for FY2024, which is 8.69% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Inventory of $13.3 million as of Q3 2025, which was up 27.63% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Inventory registered a high of $13.3 million during Q3 2025, and its lowest value of $4.7 million during Q1 2025.
  • In the last 3 years, Rigel Pharmaceuticals' Inventory had a median value of $6.6 million in 2024 and averaged $7.9 million.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Inventory soared by 328.30% in 2021, and later plummeted by 40.61% in 2024.
  • Over the past 5 years, Rigel Pharmaceuticals' Inventory (Quarterly) stood at $6.6 million in 2021, then soared by 37.82% to $9.1 million in 2022, then crashed by 39.44% to $5.5 million in 2023, then grew by 8.69% to $6.0 million in 2024, then spiked by 178.07% to $13.3 million in 2025.
  • Its Inventory was $13.3 million in Q3 2025, compared to $10.4 million in Q2 2025 and $4.7 million in Q1 2025.